Altimmune’s (ALT) Buy Rating Reiterated at HC Wainwright
HC Wainwright restated their buy rating on shares of Altimmune (NASDAQ:ALT – Free Report) in a research report report published on Wednesday,Benzinga reports. The firm currently has a $12.00 price ...
Rezolute’s (RZLT) Buy Rating Reaffirmed at HC Wainwright
HC Wainwright reaffirmed their buy rating on shares of Rezolute (NASDAQ:RZLT – Free Report) in a report published on Wednesday morning,Benzinga reports. The firm currently has a $14.00 price objective ...
Hosted on MSN1d
HC Wainwright & Co. Initiates Coverage of Vertical Aerospace (EVTL) with Buy Recommendation
Fintel reports that on February 7, 2025, HC Wainwright & Co. initiated coverage of Vertical Aerospace (NYSE:EVTL) with a Buy ...
H.C. Wainwright maintains $80 target on Corcept Therapeutics stock
H.C. Wainwright reiterated its Buy rating and $80.00 price target for Corcept Therapeutics (NASDAQ:CORT), highlighting the company's consistent growth in Korlym sales over the past eight quarters ...
Vertical Aerospace initiated with a Buy at H.C. Wainwright
H.C. Wainwright initiated coverage of Vertical Aerospace (EVTL) with a Buy rating and $12 price target The company specializes in designing ...
H.C. Wainwright Sticks to Their Buy Rating for Gold Royalty (GROY)
H.C. Wainwright analyst Heiko Ihle reiterated a Buy rating on Gold Royalty (GROY – Research Report) today and set a price target of $5.75. The ...